LGD-3303

Category: pharmacological

Pharmacological Mechanism

Quinolinone non-steroidal SARM — full AR agonist in muscle + bone, partial in prostate. Originally developed for postmenopausal osteoporosis. Less widespread than LGD-4033 in research-chem markets.

Half-Life (t½)

PO: 8h

Dosing Guidelines

• PO: Typical 10mg (Range: 5 - 15 mg)

Target Organ Systems

• endocrine
• reproductive
• musculoskeletal